STEMI患者血管生成素样蛋白2的表达及替格瑞洛与氯吡格雷的影响

张凤; 苗伟; 王淑亚; 刘楠; 苏国海; 才晓君

doi:10.13201/j.issn.1001-1439.2016.08.008

STEMI患者血管生成素样蛋白2的表达及替格瑞洛与氯吡格雷的影响

- 1 泰山医学院研究生院(山东泰安, 271016);
- 2 山东大学附属济南市中心医院心内科

详细信息

通讯作者: 才晓君,E-mail:tianchr@126.com

中图分类号: R542.2

收稿日期: 2016-04-11

Levels of angptl 2 in patients with acute ST-segment elevation myocardial infarction and comparative effect between Ticagrelor and Clopidogrel

- 1 Graduate School of Taishan Medical University, Taian, Shandong, 271016, China;
- 2 Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University

More Information

Corresponding author: CAI Xiao-jun, E-mail: tianchr@126.com

Received Date: 11 April 2016

摘要

摘要: 目的: 探讨急性ST段抬高型心肌梗死(STEMI)患者血清血管生成素样蛋白2(Angptl 2)的表达及观察替格瑞洛与氯吡格雷两种抗血小板药对其浓度的影响。方法: 入选同期入住我院心血管科患者40例为对照组,接受急诊PCI术的急性STEMI患者125例作为研究组,后者又随机分为替格瑞洛组(A组)50例(采用替格瑞洛联合阿司匹林治疗)和氯吡格雷组(B组)75例(采用氯吡格雷联合阿司匹林治疗),分别检测术前、术后24h、术后1周、术后1个月血清Angptl 2水平。结果: 急性STEMI患者Angptl 2水平显著高于对照组(P<0.05);入院时A、B两组Angptl 2水平无明显差异(P>0.05),术后24h两组血清Angptl 2水平升高,但两组差异无统计学意义(P>0.05),术后1周及术后1个月时A组较B组Angptl 2水平明显降低,差异有统计学意义(P<0.05)。结论: Angptl 2可作为急性心肌梗死的重要风险预测指标,替格瑞洛较氯吡格雷更强的降低炎性因子Angptl 2的水平,提高动脉粥样硬化斑块的稳定性。
- 血管生成素样蛋白2 /
- 替格瑞洛 /
- 氯吡格雷 /
- 急性ST段抬高型心肌梗死
Abstract: Objective: To investigate levels of serum angptl 2in patients with acute ST-segment Elevation myocardial Infarction and compare effect on its concentration between two antiplatelet medications.Method: The 40 patients at cardiovascular division in our hospital were selected as control group in the same period,125 patients with STEMI after emergency PCI were selected as experiment group and randomly divided into ticagrelor group(group A)with 50 cases,who recieved ticagrelor combined with aspirin treatment and clopidogrel group(groupB)75cases,which recieved clopidogrel combined with aspirin treatment.Angptl 2was measured before surgery and 24 hours,1week,1month after surgery respectively.Result::The levels of serum angptl 2in experimental group were significantly higher than that in control group(P<0.05).There was no statistical significance in angptl 2levels between two groups before surgery(P>0.05).Angptl 2levels of 24 hours after surgery increased in both groups,but it has no statistically significant difference(P>0.05).Angptl 2levels of 1week and 1 month after surgery were lower in group A than group B,the difference was statistically significant(P<0.05).Conclusion::Angptl 2can be used as an important risk marker in acute myocardial infarction.Ticagrelor has stronger capacity than clopidogrel in reducing Angptl 2levels and in improving the stability of atherosclerotic plaques.
- angiopoietin-like protein2 /
- Ticagrelor /
- Clopidogrel /
- ST-segment elevation myocardial infarction

HTML全文

参考文献(17)

[1]	TABATA M,KADOMATSU T,FUKUHARA S,et a1.Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance[J].Cell Metab,2009,10:178-188.
[2]	FARHAT N,THORIN-TRESCASES N,MAMARBACHI M,et al.Angiopoietin-like 2 promotes atherogenesis in mice[J].J Am Heart Assoc,2013,2:e000201.
[3]	BISOENDIAL R J,KASTELEIN J J,ETERS S L,et al.Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects[J].J Lipid Res,2007,48:952-960.
[4]	WANG Z,ZHENG H,CHEN H,et al.Elevated serum angiopoietin-like protein 2in patients with acute coronary syndrome[J].Arch Med Res,2015,46:257-64.
[5]	STOREY R F.Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study[J].Platelets,2014,25:517-525.
[6]	HATO T,TABATA M,OIKE Y.The role of angiopoietin-like proteins in angiogenesis and metabolism[J].Trends Cardiovasc Med,2008,18:6-14.
[7]	TOUSOULIS D,ANTONIADES C,KOUMSLLOS N,et al.Pro-inflammatory cytokines in acute coronary syndromes:from bench to bedside[J].Cytokine Growth Factor Rev,2006,17:225-233.
[8]	HORIO E,KADOMATSU T,MIYATA K,et al.Role of endothelial cell-derived Angptl 2in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression[J].Arterioscler Thromb Vasc Biol,2014,34:790-800.
[9]	KADOMATSU T,ENDO M,MIYATA K,et al.Diverse roles of ANGPTL 2in physiology and pathophysiology[J].Trends Endocrinol Metab,2014,25:245-254.
[10]	STOREY R F.The central role of the P(2T)receptor in amplification of human platelet activation,aggregation,secretion and procoagulant activity[J].Br J Hae-matol,2000,110:925-934.
[11]	STOREY R F.Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist ARC69931MX but not aspirin[J].Thromb Haemost,2002,88:488-494.
[12]	HEITZER T.Clopidogrel improves systemic endothelial nitric oxide bioavailabil-ity in patients with coronary artery disease:evidence for antioxidant and antiinflammatory effects[J].Arterioscler Thromb Vasc Biol,2006,26:1648-1652.
[13]	CHEN Y G.Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome[J].Chin Med J,2006,119:32-36.
[14]	PALMERINI T.A randomised study comparing the antiplatelet and antin-flammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel:Results from the DOUBLE study[J].Thromb Res,2010,125:309-314.
[15]	THOMAS M R,STOREY R F.Effect of P2Y12 inhibitors on inflammation and immunity[J].Thromb Haemost,2015,114:490-497.
[16]	张阳阳,陈魁.替格瑞洛与氯吡格雷对急性STEMI患者急诊PCI术后炎症因子的影响[J].医学与哲学,2014,35(509):31-32.
[17]	黄坚,孔小明,陆士奇,等.替格瑞洛治疗非ST段抬高型急性冠脉综合征的疗效[J].中国老年学杂志,2014,34(16):4438-4439.